Case file
Credit reporting
Complaint 9069693 Avadyne Health
Explained- Product
- Credit reporting or other personal consumer reports · Credit reporting
- Detail
- Information belongs to someone else
- Filed by
- Referral
- Company's answer
- Closed with explanation
- On time
- Yes, within 15 days
- May 21, 2024Complaint received
- May 22, 2024Sent to Avadyne Health (1 day later)
- AnsweredClosed with explanation
Closed with explanation: the company replied and explained its position, but gave no money back and changed nothing. The consumer's own description is not published with this record.
More Avadyne Health complaints about incorrect information on your report
| Received | About | Issue | State | Answer | On time |
|---|
| Jun 13, 2025 | Credit reporting | Incorrect information on your reportOld information reappears or never goes away | TN | Explained | Yes |
| May 15, 2025 | Credit reporting | Incorrect information on your reportInformation belongs to someone else | IA | Explained | Yes |
| Apr 11, 2025 | Credit reporting | Incorrect information on your reportAccount information incorrect | KS | Explained | Yes |
| Jan 12, 2025 | Credit reporting | Incorrect information on your reportInformation belongs to someone else | DC | Explained | Yes |
| Jan 24, 2024 | Payday & personal loans | Incorrect information on your reportPersonal information incorrect | PA | Explained | Yes |
| Aug 30, 2023 | Credit reporting | Incorrect information on your reportAccount status incorrect | MO | Explained | Yes |
| Mar 27, 2023 | Credit reporting | Incorrect information on your reportAccount information incorrect | PA | Explained | Yes |
| Feb 12, 2023 | Credit reporting | Incorrect information on your reportAccount status incorrect | NJ | Explained | Yes |
| Nov 13, 2022 | Credit reporting | Incorrect information on your reportAccount information incorrect | PA | Explained | Yes |
| Nov 2, 2022 | Credit reporting | Incorrect information on your reportInformation belongs to someone else | GA | Explained | No |
Discuss this complaint
No comments yet. Start the conversation - questions are welcome too.